O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al
[18] Administration Instructions Reconstitution Instructions 503A vs 503B 503A pharmacies compound products for specific patients whose prescriptions are sent by their healthcare provider
N Engl J Med 384(11):9891002 Horn DB, Kahan S, Batterham RL et al Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials
Qu et al., 2013)
The injection route eliminates most of the variables that could cause sudden effectiveness changes
Shares in Novo, which are listed in Copenhagen, dropped by more than 10% in early trading on Monday before easing back to close 5.8% down